🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Aalborg
Clinical trial register · Denmark

Clinical Trials in Aalborg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2473 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
2473
Studies in scope
all four open statuses
1402
Recruiting now
open to new participants
436
Lead sponsors
across recruiting studies
Top sites
Copenhagen 971 Aarhus 588 Odense 439 Aalborg 382 Herlev 309
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Aalborg University Hospital35 University of Aarhus22 AstraZeneca22 Merck Sharp & Dohme LLC17 Aalborg University16
Site location
Copenhagen971 Aarhus588 Odense439 Aalborg382 Herlev309
All 128 locations
Target enrolment
to

Trials with a site in Aalborg

382 of 2473 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
NCT07474961Waldenstrom Macroglobulinaemia, Multiple Myeloma
DrugsLinvoseltamab·Talquetamab·Elranatamab·Teclistamab
Anne Louise Tølbøll Sørensen
Phase 4
400
Copenhagen, Aalborg, Aarhus, Odense, Roskilde
2027-03
Not yet open
Molecularly Tailored Therapy in Advanced Pancreatic Cancer
NCT07802418Pancreatic Cancer
Herlev Hospital
Phase 2
1,200
Aalborg, Aarhus, Herlev, Vejle
2026-10
Not yet open
Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer
NCT07432802Lung Cancer (NSCLC)
Aarhus University Hospital
Not applicable
182
Copenhagen, Aalborg, Aarhus N, Odense
2026-09-01
Not yet open
Oral Switch in Pediatric Bloodstream Infections
NCT07791914Bloodstream Infection, Bacteremia Sepsis
Ulrikka Nygaard
Phase 4
150
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Gødstrup, Herlev, Hillerød
2026-09-01
By invitation
Comparison of Two Mechanical Rotation Chairs With Diagnostics of Benign Paroxysmal Positional Vertigo.
NCT07772973Benign Paroxysmal Positional Vertigo (BPPV)
Aalborg University Hospital
Observational
200
Aalborg
2026-09-01
Not yet open
Rapid or Ultra-rapid Diagnosis of Myocardial Infarction Using High-Sensitivity Cardiac Troponin on Hospital Presentation
NCT07727135Coronary Syndrome, Acute, Myocardial Infarction, Coronary Artery Disease, Cardiovascular Diseases
Herlev and Gentofte Hospital
Not applicable
28,000
Aalborg, Bispebjerg, Esbjerg, Gødstrup, Herlev, Hillerød, Hvidovre, Nykøbing Falster
2026-09-01
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993Chronic Kidney Disease
DrugElecoglipron
AstraZeneca
Phase 3
7,000
Aalborg, Aarhus, Copenhagen E, Herlev, Herning, Holbæk, Roskilde
2026-08-21
Recruiting
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
NCT07686263Schizophrenia
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
472
Aarhus, Hovedvejen 19, Glostrup, Aalborg
2026-08-20
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245Pulmonary Disease, Chronic Obstructive
DrugBrenipatide
Eli Lilly and Company
Phase 2
606
Aalborg, Aarhus, Copenhagen, Hvidovre, Roskilde, Vejle
2026-08-07
Not yet open
The Impact of Back-supporting Exoskeletons for Manual Order Picking in Danish Warehouses - The RELAX Project
NCT07561112Work-Related Musculoskeletal Disorders
Aalborg University
Not applicable
90
Aalborg
2026-08-01
Recruiting
Disease Activity Monitoring in Patients With Giant Cell Arteritis Study
NCT07552636Giant Cell Arteritis (GCA)
University of Aarhus
Observational
175
Aalborg, Aarhus, Glostrup Municipality, Horsens, Silkeborg, Svendborg, Vejle
2026-05-06
Recruiting
Bracing After Ankle Fracture
NCT07163091Ankle Fracture, Rehabilitation, Recovery
Odense University Hospital
Not applicable
1,400
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Hillerød, Hvidovre
2026-04-23
Recruiting
Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
NCT07478003STEMI - ST Elevation Myocardial Infarction
DrugsNaCl·Methylprednisolone
Thomas Engstrom
Phase 3
5,204
Aalborg, Aarhus, Copenhagen, Odense
2026-04-20
Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
NCT07522073Solid Tumors
DrugINCB161734
Incyte Corporation
Phase 3
588
Aalborg, Århus N, Herlev, Køge, Odense C, Vejle
2026-04-09
By invitation
Evaluating the Use of an App in Pleural Disease: Algorithm-supported Clinical Decision Making Versus Usual Care
NCT07625176Pleural Diseases, Pneumothorax Spontaneous Primary, Pneumothorax Spontaneous Secondary, Pleural Effusion
Zealand University Hospital
Not applicable
828
Aalborg, Aarhus, Amager, Esbjerg, Hillerød, Hvidovre, Kolding, Køge
2026-04-01
Not yet open
Protocol for a Randomized Controlled Trial Comparing the Effectiveness of Mechanical Diagnosis and Therapy Versus Generalized Exercise for Reducing Pain in Surgeons With Chronic Spinal Pain
NCT07293130Chronic Spinal Pain
Claus Kjærgaard
Not applicable
62
Aalborg
2026-03-30
Not yet open
QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy
NCT07466212Cancer, Type 2 Diabetes
Odense University Hospital
Observational
920
Aalborg, Aarhus, Herlev, Vejle
2026-03-10
Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849CRC (Colorectal Cancer)
DrugsINCA33890·Folfox·Bevacizumab
Incyte Corporation
Phase 3
700
Aalborg, Odense C, Roskilde, Vejle
2026-03-05
Not yet open
Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest
NCT03176186Post-Cardiac Arrest Syndrome
Invero Pharma, Inc.
Phase 3
1,436
Aalborg, Copenhagen
2026-03
Recruiting
SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to Reduce School Fragmentation for Children Undergoing Cancer Treatment
NCT07398677School Attendance, Academic Level, Childhood Cancer Survivors, Social Well-being
Rigshospitalet, Denmark
Not applicable
128
Aalborg, Aarhus, Copenhagen
2026-02-20
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT07318558Ovarian Neoplasms, Ovarian Cancer
DrugsSacituzumab tirumotecan·Bevacizumab
Merck Sharp & Dohme LLC
Phase 3
900
Herlev, Aalborg, Aarhus, Odense
2026-02-16
Not yet open
Off-set Analgesia Induced by Cold Temperature
NCT07395869Pain
Aalborg University
Not applicable
30
Aalborg
2026-02-15
Not yet open
A New Model to Induce Itch and Inflammation
NCT07395882Itching
Aalborg University
Not applicable
28
Aalborg
2026-02-15
Recruiting
Does AI Make Clinicians More Appropriately Confident? A Randomized Study in Preterm Birth Prediction
NCT07402668Preterm Birth, Artificial Intelligence (AI) in Diagnosis
Rigshospitalet, Denmark
Not applicable
125
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Gødstrup, Herlev, Hillerød
2026-02-03
Recruiting
Measuring Fluid Buildup in Cancer Patients
NCT07443618Cancer, Oedema, Bioelectrical Impedance, Lymphoedema
Jens Rikardt Andersen
Observational
46
Aalborg
2026-02-01
Recruiting
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
NCT06980480Multiple Myeloma, Secondary Immunodeficiency
Takeda
Phase 3
183
Aalborg, Aarhus, Copenhagen, Odense
2026-01-14
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285Overweight, Obesity
DrugsCagrilintide·Semaglutide
Novo Nordisk A/S
Phase 3
460
Aalborg, Holbæk
2026-01-08
By invitation
Improving Patient-centered Communication and Antibiotic Use With Information Sheets for Acute Respiratory Tract Infections: A Study Protocol
NCT07383350Acute Bronchitis, ACUTE SINUSITIS, Sore Throat
Research Unit for General Practice in Aalborg
Not applicable
1,144
Aalborg
2026-01-05
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
NCT07218809Epithelial Ovarian Cancer
DrugsTorvutatug samrotecan·MIRV·Mirvetuximab Soravtansine·Pegylated liposomal doxorubicin
AstraZeneca
Phase 3
1,100
Aalborg, Aarhus, Odense, Vejle
2025-12-29
Recruiting
Tonic Pain and Transauricular Vagal Nerve Stimulation
NCT07325058Experimental Pain in Healthy Human Subjects
Aalborg University
Not applicable
36
Aalborg
2025-12-18
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Aalborg, Aarhus, Copenhagen, Næstved
2025-12-12
Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT07222800Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms, Neoplasms by Site
DrugsPF-08634404·Avastin·Bevacizumab
Pfizer
Phase 3
800
Odense C, Vejle, Aalborg, Copenhagen
2025-12-11
Recruiting
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
NCT06910943Choline Deficiency, Liver Injury
Protara Therapeutics
Phase 2/3
129
Aalborg, Copenhagen
2025-12-10
Recruiting
Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes
NCT07240012Diabete Type 1, Pregnancy Complications
Rigshospitalet, Denmark
Not applicable
305
Aalborg, Aarhus, Copenhagen, Odense
2025-12-01
Recruiting
Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.
NCT07263321Depressive Disorder, Depression - Major Depressive Disorder, Depressive Disorder, Major Depressive Disorder, Depressive Disorders
Aalborg University Hospital
Not applicable
171
Aalborg
2025-12
Not yet open
The Impact of De-implementing Urine Dipsticks for Diagnosis of UTIs in Hospitals
NCT06750666Urinary Tract Infections, Diagnostic Techniques and Procedures, Point-of-Care Testing, Anti-Bacterial Agents
Jacob Bodilsen
Observational
480,000
Aalborg, Hjørring
2025-12
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
NCT07166094Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
DrugRina-S
Genmab
Phase 3
660
Aalborg
2025-11-28
Recruiting
A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)
NCT07012629Covert Brain Infarction
DrugsRosuvastatin·Atorvastatin·Clopidogrel·Aspirin
Aarhus University Hospital
Phase 3
1,652
Aalborg, Aarhus, Copenhagen, Herlev, Herning, Kolding, Odense, Roskilde
2025-11-26
By invitation
Optical Coherence Tomography in Acute Vessel Evaluation
NCT07422688Ischemic Heart Disease, Ischemic Coronary Artery Disease, ACS (Acute Coronary Syndrome)
Aarhus University Hospital Skejby
Not applicable
3,000
Aalborg, Aarhus N, København Ø, Odense, Roskilde
2025-11-23
Recruiting
The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
NCT06185296Type 2 Diabetes Treated With Insulin
Aalborg University Hospital
Not applicable
51
Aalborg
2025-11-15
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
NCT07059845Ovarian Cancer
DrugsMirvetuximab Soravtansine·Bevacizumab·Carboplatin
AbbVie
Phase 2
400
Herlev, Aalborg, Odense
2025-11-13
Active, closed
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07170150Alzheimers Disease
DrugTrontinemab
Hoffmann-La Roche
Phase 3
1,060
Aalborg, Aarhus N, København Ø
2025-11-12
Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
NCT07088926Bronchiectasis With Pseudomonas Aeruginosa Colonization
DrugAZD0292
AstraZeneca
Phase 2
435
Aalborg, Aarhus N, Hvidovre, Odense C, Roskilde
2025-11-06
Recruiting
The AIDPRO-CRC Trial
NCT06645015Colo-rectal Cancer
Zealand University Hospital
Not applicable
1,200
Aalborg, Copenhagen NV, Herning, Hillerød, Hvidovre, Randers, Svendborg, Viborg
2025-10-24
Active, closed
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT07076121Pancreatic Ductal Adenocarcinoma
DrugsNavlimetostat·Nab-paclitaxel·Gemcitabine
Bristol-Myers Squibb
Phase 2/3
470
Copenhagen, Aalborg, Odense, Vejle
2025-10-23
Recruiting
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
NCT07140913Mania, Bipolar Disorder
DrugKarXT
Bristol-Myers Squibb
Phase 3
424
Hillerød, Aalborg, Glostrup Municipality
2025-10-08
Recruiting
Optimized Expansion of the Implanted Transcatheter Aortic Valve
NCT07042529Aortic Stenosis Disease, Valvular Heart Disease
Ole De Backer
Not applicable
1,010
Aa, Aalborg, Copenhagen, Odense C
2025-10-05
Recruiting
Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes
NCT06745544Type 2 Diabetes, Osteoporosis, Diabetic Neuropathies, Fall Prevention
Aalborg University Hospital
Not applicable
490
Aalborg
2025-10-01
Recruiting
Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer
NCT07234656Fear of Cancer Recurrence, Renal Cell Carcinoma (Kidney Cancer)
Brigitta Rasmussen Villumsen
Observational
105
Aalborg, Aarhus, Herning
2025-09-30
Recruiting
The Post-ICU Pain Study
NCT07180407Chronic Pain, Post Intensive Care Unit Syndrome, Quality of Life, Pain Disorder
Zealand University Hospital
Observational
800
Aalborg, Køge, Nykøbing Falster, Roskilde
2025-09-23
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
NCT07116967Plaque Psoriasis
DrugsUstekinumab·Deucravacitinib
Bristol-Myers Squibb
Phase 3
3,040
Copenhagen, Aalborg, Aarhus, Hellerup, Herlev
2025-09-22
Not yet open
Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy
NCT07185958Brain Metastases, Bone Metastases, Head and Neck Cancer, Lung Cancer
Aalborg University Hospital
Observational
80
Aalborg, Herlev, Odense
2025-09-22
Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
NCT07053423Chronic Obstructive Pulmonary Disease
DrugDupilumab
Sanofi
Phase 4
218
Aalborg, Vejle
2025-09-22
Recruiting
Early Implementation of Plyometric Exercises in the Rehabilitation of Individuals Suffering From Lower-Extremity Tendinopathies
NCT06774547Achilles Tendinopathy, Patellar Tendinopathy, Plantar Fasciopathy
Aalborg University
Not applicable
120
Aalborg
2025-09-18
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209Chronic Obstructive Pulmonary Disease
DrugLunsekimig
Sanofi
Phase 3
942
Aalborg, Hvidovre, Næstved, Odense, Vejle
2025-09-16
Recruiting
Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue
NCT06905587Brain Tumor, Pediatric, Cancer-related Fatigue, Methylphenidate
DrugMethylphenidate
Odense University Hospital
Phase 3
50
Aalborg, Aarhus, Copenhagen, Odense
2025-09-02
Recruiting
A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma
NCT06621407Chronic Subdural Hematoma, Surgical Procedures, Operative, Recurrence, Mortality
Aalborg University Hospital
Not applicable
354
Aalborg, Aarhus, Copenhagen, Odense
2025-09-01
Not yet open
Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration
NCT07165574Frailty in Older Adults, Functional Decline, Anticholinergic Syndrome
Aalborg University Hospital
Observational
100
Aalborg
2025-09-01
Not yet open
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
NCT06788340Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Odense University Hospital
Phase 4
166
Aalborg, Esbjerg, Hvidovre, Nyborg, Odense, Vejle
2025-09-01
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06982521PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer
DrugsCapivasertib·Fulvestrant
Relay Therapeutics, Inc.
Phase 3
540
Aalborg, Næstved, Sønderborg
2025-08-26
Recruiting
Algorithm Guided Treatment Versus Treatment as Usual (TAU) for Patients With Treatment Resistant Depression
NCT07080723Treatment Resistant Depression (TRD)
Aalborg University Hospital
Phase 4
80
Aalborg
2025-08-13
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Aalborg, Aarhus N, Copenhagen, Odense, Roskilde
2025-08-05
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433Atherosclerotic Cardiovascular Disease, Overweight, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
12,800
Aalborg, Aarhus N, Esbjerg, Gandrup, Herlev, Herning, Holbæk, Hvidovre
2025-07-25
Recruiting
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)
NCT07569458Ischemic Heart Disease (IHD), Anxiety, Depression
University of Southern Denmark
Not applicable
30
Aalborg, Aarhus, Roskilde
2025-07-04
Recruiting
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352Alzheimers Disease
Hoffmann-La Roche
Phase 3
80,000
Aalborg, Aarhus N, København Ø
2025-07-02
Recruiting
Progressive Resistance Training for Adults With External Snapping Hip
NCT06924164External Snapping Hip, Coxa Saltans External
Aarhus University Hospital
Not applicable
100
Aalborg, Aarhus N, Copenhagen, Herning, Hillerød, Horsens, Hvidovre, Køge
2025-07-01
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca
Phase 2
987
Aalborg, Aarhus, Esbjerg, Hvidovre, Odense C, Roskilde
2025-06-27
Recruiting
Ultrasound Simulation or Traditional Ultrasound Training for General Practitioners?
NCT07127588Ultrasound Training
Aalborg University
Not applicable
24
Aalborg
2025-06-26
Recruiting
The Intensive Care Platform Trial
NCT06667999Intensive Care Patients, Intensive Care Unit Patients, Critical Illness
DrugAlbumin
Anders Perner
Phase 4
10,000
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Herning, Hillerød
2025-06-26
By invitation
MDR - Comprehensive Primary Revision Stems PMCF
NCT06788717Shoulder Pain, Shoulder Injuries, Shoulder Fractures, Shoulder Disease
Zimmer Biomet
Observational
59
Aalborg
2025-06-19
Recruiting
Assessing the Quality of Telephone Follow-Up After Spine Surgery
NCT07173413Low Back Pain
Aalborg University Hospital
Observational
200
Aalborg
2025-06-12
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsSonrotoclax·Venclexta·Obinutuzumab·Venetoclax
BeOne Medicines
Phase 3
630
Aalborg, Copenhagen, Odense, Roskilde
2025-06-11
Recruiting
Remote Monitoring of Cardiac Mechanics in Heart Failure Patients
NCT06885164Heart Failure, Heart Failure - NYHA II - IV
Aalborg University
Observational
200
Aalborg, Herlev
2025-06-11
Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06340568Endometrial Cancer
DrugsDoxorubicin·Docetaxel·Paclitaxel
BioNTech SE
Phase 3
480
Aalborg, Copenhagen, Herlev, Odense
2025-06-10
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892Bronchiectasis
DrugVerducatib
Boehringer Ingelheim
Phase 3
1,755
Aalborg, Aarhus N, Hvidovre, København Ø, Vejle
2025-06-09
Recruiting
Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
NCT07187583Chronic Rhinosinusitis With Nasal Polyps
Rigshospitalet, Denmark
Phase 4
135
Aalborg, Aarhus, Copenhagen, Esbjerg, Herning, Hillerød, Køge, Odense
2025-06-05
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06852222Leukemia, Myeloid, Acute
DrugsBleximenib·Azacitidine·Venetoclax
Janssen Research & Development, LLC
Phase 3
600
Aalborg, Copenhagen, Odense, Roskilde
2025-06-04
Recruiting
Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
NCT06781879Non-Muscle Invasive Bladder Cancer
DrugMitomycin C
Jakob Kristian Jakobsen
Phase 4
272
Aalborg, Aarhus N, Herlev, Roskilde
2025-06-01
By invitation
Changes in Children and Young People's Well-being and Parental Stress While Seeking Help at CAMHS in Denmark. How Does Waiting Affect CYP and Their Parents Before, During and After CAMHS Assessments.
NCT07553104Mental Health Help-Seeking, Mental Health Difficulties, Help-Seeking Behavior, Waiting Times, Patient Pathways, Effect of Lifestyle-related, Clinical and Demographic Parameters on Outcomes
Aalborg University Hospital
Observational
200
Aalborg
2025-06-01
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
NCT06952504Endometrial Cancer
DrugsSacituzumab tirumotecan·Docetaxel·Paclitaxel·Cisplatin
Merck Sharp & Dohme LLC
Phase 3
1,123
Copenhagen, Aarhus, Aalborg, Roskilde
2025-05-22
Recruiting
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
NCT06697301Advanced Melanoma
DrugsEIK1001·Keytruda·Pembrolizumab
Eikon Therapeutics
Phase 2/3
740
Aarhus, Aalborg
2025-05-22
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737Prostate Cancer, Prostatic Neoplasms
DrugsIfinatamab Deruxtecan·Prednisone·Docetaxel
Merck Sharp & Dohme LLC
Phase 3
1,440
Herlev, Aalborg, Odense, Vejle
2025-05-13
Recruiting
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
NCT06652438Acute Myeloid Leukemia, Adult
DrugRevumenib
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Aalborg, Aarhus N, Copenhagen, Odense
2025-05-05
Recruiting
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
NCT06939088Alcohol Use Disorder, Alcohol Abuse/Dependence, Alcohol Dependence, Alcoholism
DrugTirzepatide
Anders Fink-Jensen, MD, DMSci
Phase 2
108
Aalborg, Frederiksberg
2025-05-05
Recruiting
Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction
NCT06710184NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Acute Myocardial Infarction (AMI)
DrugAspirin
University of Aarhus
Phase 4
5,076
Herning, Horsens, Viborg, Aalborg, Aabenraa, Esbjerg, Kolding, Odense
2025-05-01
Recruiting
Danish Prognostic Research on Embryonic Diagnostics Involving Chromosomal Testing.
NCT06915311Aneuploidy
Christian Liebst Frisk Toft
Observational
220
Aalborg
2025-04-22
Active, closed
A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
NCT06934226Plaque Psoriasis
DrugsIcotrokinra·Ustekinumab
Janssen Research & Development, LLC
Phase 3
752
Aalborg, Aarhus, Hellerup, København NV, Odense, Roskilde
2025-04-15
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
NCT06824467Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
DrugsSteroid mouthwash (dexamethasone·Mvasi·Acetaminophen·Avastin
Merck Sharp & Dohme LLC
Phase 3
770
Copenhagen, Herlev, Aalborg, Vejle
2025-04-09
Recruiting
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949Metastatic Breast Cancer, Response Monitoring
Odense University Hospital
Not applicable
420
Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Odense, Sønderborg, Vejle
2025-04-02
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
NCT06989112Endometrial Cancer
DrugsTaxotere·Rilvegostomig·Paraplatin·Taxol
AstraZeneca
Phase 3
600
Aalborg, Herlev, København Ø, Odense
2025-03-27
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261Chronic Obstructive Pulmonary Disease (COPD)
DrugTezepelumab
AstraZeneca
Phase 3
990
Aalborg, Hvidovre, Næstved, Odense C, Vejle
2025-03-25
Recruiting
Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure
NCT06653725Acute Heart Failure (AHF)
Aarhus University Hospital
Phase 2
250
Aalborg, Aarhus N, Copenhagen, Herning, Hvidovre, Odense, Viborg
2025-03-20
Recruiting
Strategies for Defibrillation During Out-of-Hospital Cardiac Arrest
NCT06781892Cardiac Arrest (CA)
Lars Wiuff Andersen
Not applicable
909
Aalborg, Aarhus N, Ballerup Municipality, Næstved, Vejle
2025-03-15
Recruiting
Thrombolysis in Factor Xa-inhibitors Trial
NCT06878066Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke, Acute Ischemic Stroke
DrugsAlteplase·Tenecteplase
Guri Hagberg
Phase 3
300
Aalborg, Aarhus
2025-03-14
Active, closed
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
NCT06764485Metastatic Castration-resistant Prostate Cancer
DrugsAbiraterone·Enzalutamide·Docetaxel
Celgene
Phase 3
960
Copenhagen, Aarhus, Aalborg
2025-03-13
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723Chronic Kidney Disease and Hypertension
DrugBaxdrostat/dapagliflozin
AstraZeneca
Phase 3
5,000
Aalborg, Aarhus, Copenhagen E, Herlev, Herning, Holbæk, Kolding
2025-03-03
Recruiting
Revascularization of Calcified Coronary Arteries
NCT07724184Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD), Percutaneous Coronary Intervention (PCI)
Aalborg University Hospital
Observational
100
Aalborg
2025-03-01
By invitation
Maternal Cardiovascular Adaption to Pregnancy in IVF Patients Following Frozen Embryo Transfer (FET)
NCT06471140IVF, Frozen Embryo Transfer (FET), Cardiovascular Adaption, Magnetic Resonance Imaging (MRI)
Aalborg University Hospital
Observational
75
Aalborg
2025-03-01
Recruiting
A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures
NCT06864130Osteoporosis in Post-menopausal Women
DrugAlendronate
Odense University Hospital
Phase 4
1,400
Aalborg, Copenhagen, Esbjerg, Herlev, Hillerød, Hvidovre, Odense
2025-02-21
Not yet open
Treatment of Bulbar Urethral Strictures With Optilume Drug-Coated Balloons in an Untreated Population
NCT06827210Urethral Stricture, Urethral Stricture, Anterior, Urethral Stricture, Male, Urethral Stricture Less Than 2 cm
Aalborg University Hospital
Not applicable
140
Gødstrup, Aalborg, Hjørring
2025-02-07
Rows per page Showing 1–100 of 382
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-denmark/city/aalborg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,473 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 382 of those studies with a site in Aalborg.

How many clinical trials are recruiting in Aalborg?

206 of the 382 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 23 have not yet opened recruitment, 142 are active but closed to new participants, and 11 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Aalborg), 382 studies
PhaseStudiesRecruitingShare
Phase 31396236.4%
Not applicable996025.9%
Observational623816.2%
Phase 237169.7%
Phase 433228.6%
Phase 2/3741.8%
Phase 1/2541.3%

Most active sponsors

Lead sponsors with the most studies (Aalborg)
Lead sponsorStudiesRecruiting
Aalborg University Hospital3521
AstraZeneca2212
University of Aarhus2217
Merck Sharp & Dohme LLC1710
Aalborg University1611
Odense University Hospital1511
Rigshospitalet, Denmark1411
Aarhus University Hospital96
Hoffmann-La Roche93
Janssen Research & Development, LLC93
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.